We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Bitter with the sweet

16 Dec 2021 By Pete Sweeney

The biggest listing on the overheated STAR market this year bombed as shares of biotech giant BeiGene fell 16% on their debut. That finally adds risk to a once-safe bet on triple-digit first-day pops. Regulators fretting about the speculative stock mania can relax a bit.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)